US2023323314A1PendingUtilityA1
Increasing productivity of e. coli host cells that functionally express p450 enzymes
Est. expiryAug 21, 2035(~9.1 yrs left)· nominal 20-yr term from priority
Inventors:Jason DonaldChristopher PirieLiwei LiHuey-Ming MakSrishti TibrewalaAjikumar Parayil Kumaran
C12N 9/0079C12N 9/00C12N 15/52C12N 15/70C12P 5/007C12P 19/56C07K 2319/03
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the production of chemical species in bacterial host cells. Particularly, the present invention provides for the production of chemical species in Escherichia coli (E. coli) host cells that functionally express engineered P450 enzymes.
Claims
exact text as granted — not AI-modified1 . A method for biosynthesis of one or more chemical species in E. coli, comprising:
expressing one or more biosynthetic pathways in E. coli , the one or more biosynthetic pathways comprising at least one membrane-anchored P450 enzyme having a transmembrane domain derived from an E. coli inner membrane cytoplasmic C-terminus protein, and culturing the E. coli to produce the one or more chemical species from the biosynthetic pathway(s).
2 . The method of claim 1 , wherein the E. coli does not exhibit a substantially stressed phenotype during the culturing.
3 . The method of claim 1 , wherein the E. coli expresses at least two, at least three, or at least four recombinant enzymes.
4 . The method of claim 3 , wherein the biosynthetic pathway(s) produce a secondary metabolite through the overexpression of at least two foreign genes.
5 . The method of claim 4 , wherein the biosynthetic pathway(s) produce a secondary metabolite through the overexpression of at least three foreign genes, at least four foreign genes, or at least five foreign genes.
6 . The method of claim 1 , wherein the E. coli contains an overexpression of at least two E. coli genes.
7 . The method of claim 6 , wherein the E. coli overexpresses at least one gene in the MEP pathway.
8 . The method of claim 6 , wherein at least one gene is expressed by a strong promoter.
9 - 34 .
35 . The method of claim 1 , wherein at least one membrane anchor is a single pass transmembrane domain derived from an E. coli gene selected from waaA, ypfN, yhcB, yhbM, yhhm, zipA, ycgG, djlA, sohB, lpxK, F110, motA, htpx, pgaC, ygdD, hemr, and ycls, or derivative thereof.
36 . (canceled)
37 . The method of claim 1 , wherein the P450 enzyme has a deletion of part or all of its native N-terminal transmembrane domain.
38 - 53 . (canceled)
54 . A method for producing a product comprising one or more terpenoid compounds, comprising:
expressing a terpenoid biosynthetic pathway in E. coli , the biosynthetic pathway comprising at least one membrane-anchored P450 enzyme having a transmembrane domain derived from an E. coli inner membrane cytoplasmic C- terminus protein; and culturing the E. coli to produce the one or more terpenoids from the biosynthetic pathway; recovering the terpenoid(s) from the culture; and incorporating the terpenoid into a product.
55 . The method of claim 54 , wherein the E. coli does not exhibit a substantially stressed phenotype during the culturing.
56 . The method of claim 54 , wherein the E. coli expresses at least two, at least three, or at least four recombinant enzymes.
57 . The method of claim 56 , wherein the terpenoid biosynthetic pathway comprises the overexpression of at least two foreign genes.
58 - 104 . (canceled)
105 . An E. coli host cell expressing one or more recombinant biosynthetic pathways, where the biosynthetic pathways comprise at least one membrane-anchored P450 protein having a transmembrane domain derived from an E. coli inner membrane cytoplasmic C-terminus protein.
106 - 131 .
132 . The host cell of claim 105 , wherein at least one membrane anchor is a single pass transmembrane domain derived from an E. coli gene selected from waaA, ypfN, yhcB, yhbM, yhhm, zipA, ycgG, djlA, sohB, lpxK, F11O, motA, htpx, pgaC, ygdD, hemr, and ycls, or derivative thereof.
133 . (canceled)
134 . The host cell of claim 105 , wherein the P450 enzyme has a deletion of part or all of its native N-terminal transmembrane domain.
135 - 146 . (canceled)
147 . A plant P450 enzyme comprising an N-terminal truncation and a single-pass transmembrane region derived from an E. coli inner membrane cytoplasmic C-terminus protein.
148 . The enzyme of claim 147 , wherein the membrane-anchored P450 is selected from CiVO, HmPO, LsGAO, BsGAO, NtEAO, SrKO, SrKAH, AtKAH, ZzHO, CpVO, MsL6OH, NtVO, StVO, AtKO, Ci2VO, AaAO, and Taxus 5-alpha hydroxylase, or derivative thereof.
149 - 162 . (canceled)
163 . A polynucleotide encoding the enzyme of claim 147 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.